日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

On the value of microsurgical resection compared to biopsy in elderly glioblastoma patients: A retrospective multicenter analysis and scoring system proposal

老年胶质母细胞瘤患者显微外科切除术与活检的价值比较:一项回顾性多中心分析及评分系统建议

Pöppe, Johannes P; Buchta, Melanie; Demetz, Matthias; Freyschlag, Christian F; Kerschbaumer, Johannes; Thomé, Claudius; Stefanits, Harald; Gahleitner, Saskia; Gruber, Andreas; Steinbacher, Jürgen; Machegger, Lukas; Geroldinger, Martin; Zimmermann, Georg; Kraus, Theo F J; Sotlar, Karl; Korja, Miikka; Griessenauer, Christoph J; Schwartz, Christoph

Characterization, immune cell phenotyping and differential gene expression analysis of brain metastases and primary breast cancer samples

脑转移瘤和原发性乳腺癌样本的特征分析、免疫细胞表型分析和差异基因表达分析

Gassner, Franz Josef; Rinnerthaler, Gabriel; Castagnaviz, Vanessa; Gonzalez-Martinez, Alejandra; Parigger, Thomas; Drothler, Stephan; Greil, Richard; Geisberger, Roland; Kraus, Theo F J; Romagna, Alexander; Schwartz, Christoph; Ladisich, Barbara; Sotlar, Karl; Hauser-Kronberger, Cornelia; Alinger-Scharinger, Beate; Steiner, Markus; Zaborsky, Nadja; Gampenrieder, Simon Peter

Loss of CDKN2A/B is a Hallmark of RTK II Glioblastomas

CDKN2A/B 的缺失是 RTK II 型胶质母细胞瘤的标志性特征。

Langwieder, Celina K; Hölzl, Dorothee; Hutarew, Georg; Schlicker, Hans U; Alinger-Scharinger, Beate; Schwartz, Christoph; Sotlar, Karl; Kraus, Theo F J

Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial

新辅助阿特珠单抗联合双重 HER2 阻断疗法和表柔比星治疗早期 HER2 阳性乳腺癌女性患者:随机 II 期 ABCSG-52/ATHENE 试验

Rinnerthaler, Gabriel; Egle, Daniel; Bartsch, Rupert; Schmitt, Clemens A; Petzer, Andreas; Balic, Marija; Petru, Edgar; Denison, Ursula; Singer, Christian F; Bjelic-Radisic, Vesna; Gampenrieder, Simon Peter; Knauer, Michael; Sotlar, Karl; Brunner, Christine; Posch, Florian; Hlauschek, Dominik; Sölkner, Lidija; Bago-Horvath, Zsuzsanna; Filipits, Martin; Gili, Manuela; Ritter, Magdalena; Wieser, Verena; Albertini, Carmen; Zaborsky, Nadja; Weiss, Lukas; Marhold, Maximilian; Schneeweiss, Bruno; Pusch, Renate; Gnant, Michael; Greil, Richard

ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34

ABCSG 34 试验中乳腺癌患者诊断性核心活检组织中 ESR1、PGR、ERBB2 和 MKi67 mRNA 的表达

Kacerovsky-Strobl, Stephanie; Deutschmann, Christine; Hlauschek, Dominik; Bago-Horvath, Zsuzsanna; Singer, Christian F; Bartsch, Rupert; Greil, Richard; Sotlar, Karl; Rinnerthaler, Gabriel; Petru, Edgar; Lax, Sigurd F; Egle, Daniel; Pichler, Angelika; Bodó, Koppány; Petzer, Andreas L; Moinfar, Farid; Weidler, Jodi; Bates, Michael; Dubsky, Peter; Gnant, Michael; Filipits, Martin

Ultra-Fast Intraoperative IDH-Mutation Analysis Enables Rapid Stratification and Therapy Planning in Diffuse Gliomas

超快速术中IDH突变分析可实现弥漫性胶质瘤的快速分层和治疗计划制定

Kraus, Theo F J; Alinger-Scharinger, Beate; Langwieder, Celina K; Mol, Anna; Aleksic, Tereza; van Merkestijn, Brain; Schlicker, Hans U; Spendel, Mathias; Pöppe, Johannes; Schwartz, Christoph; Griessenauer, Christoph J; Sotlar, Karl

Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis

髓系肉瘤表现出较高的MAPK/ERK通路激活突变频率,并与克隆性造血相关。

Nann, Dominik; Schade, Tim-Colin; Overkamp, Mathis; Mahmutovic, Lejla; Bag, Eyyub; Forchhammer, Stephan; Slotta-Huspenina, Julia; Boudova, Ludmila; Sotlar, Karl; Quintanilla-Martinez, Leticia; Bonzheim, Irina; Fend, Falko

Gene Expression Profiling Provides an Improved Characterization of CD79B-Mutated Diffuse Large B-Cell Lymphomas

基因表达谱分析可更好地表征CD79B突变型弥漫性大B细胞淋巴瘤

Grossmann, Luis; Jagla, Wolfgang; Bettstetter, Marcus; Bertz, Simone; Schwarz-Furlan, Stephan; Richter, Thomas; Dechow, Tobias; Decker, Thomas; Dreyling, Martin; Sotlar, Karl; Bartsch, Harald; Hartmann, Arndt; Honecker, Julius; Gaumann, Andreas

Comparison of Prosigna® Assay and Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Results in Early-Stage Breast Cancer Patients

早期乳腺癌患者Prosigna®检测与尿激酶型纤溶酶原激活剂/纤溶酶原激活剂抑制剂-1检测结果的比较

Rickerl, Laura; Bartsch, Harald; Harbeck, Nadia; Hofmann, Daniel Maria; Kolben, Thomas; Degenhardt, Tom; Sotlar, Karl; Wuerstlein, Rachel

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts

组织驻留髓系细胞和组织细胞在健康和疾病中的作用:新兴概念

Valent, Peter; Wojta, Johann; Kovanen, Petri T; Hermine, Olivier; Fend, Falko; Sotlar, Karl; Greinix, Hildegard; Geissler, Klaus; Hartmann, Karin; Schwaab, Juliana; Herling, Marco; Boccuni, Laura; Kazianka, Lukas; John, Max Vincent; Sperr, Wolfgang R; Zierfuss, Carina; Tzankov, Alexandar; Sillaber, Christian; Minkov, Milen; Hoermann, Gregor; Collin, Matthew; Horny, Hans-Peter; Haferlach, Torsten; Sibilia, Maria; Haroche, Julien; La Rosée, Paul; Orfao, Alberto; Arock, Michel